Cargando…

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

The risk‐benefit ratio associated with the use of repurposed drugs to treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)‐related infectious coronavirus disease 2019 (COVID‐19) is complicated because benefits are awaited, not proven. A thorough literature search was conducted to sourc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michaud, Veronique, Dow, Pamela, Al Rihani, Sweilem B., Deodhar, Malavika, Arwood, Meghan, Cicali, Brian, Turgeon, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877829/ https://www.ncbi.nlm.nih.gov/pubmed/32888379 http://dx.doi.org/10.1111/cts.12882

Ejemplares similares

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
por: Deodhar, Malavika, et al.
Publicado: (2020)

ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
por: Michaud, Veronique, et al.
Publicado: (2020)

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy
por: Al Rihani, Sweilem B., et al.
Publicado: (2020)

Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study
por: Smith, Matt K., et al.
Publicado: (2021)

Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level
por: Al Rihani, Sweilem B., et al.
Publicado: (2021)

Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
por: Deodhar, Malavika, et al.
Publicado: (2021)

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models
por: Al Rihani, Sweilem B., et al.
Publicado: (2021)

Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare Costs
por: Michaud, Veronique, et al.
Publicado: (2021)

Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition
por: Long, Tao, et al.
Publicado: (2021)

Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly
por: Ha, Meghan, et al.
Publicado: (2022)

Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
por: Deodhar, Malavika, et al.
Publicado: (2021)

Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity
por: Darakjian, Lucy, et al.
Publicado: (2021)

Precision medication: An illustrative case series guiding the clinical application of multi‐drug interactions and pharmacogenomics
por: Bain, Kevin T., et al.
Publicado: (2019)

Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall
por: Russell, Joshua, et al.
Publicado: (2023)

Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism
por: Michaud, Veronique, et al.
Publicado: (2010)

The Blood–Brain Barrier in Health and Disease
por: Al Rihani, Sweilem B., et al.
Publicado: (2023)

A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human Duodenum
por: Gravel, Sophie, et al.
Publicado: (2019)

QT Assessment in Early Drug Development: The Long and the Short of It
por: Lester, Robert M., et al.
Publicado: (2019)

Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
por: Fenneteau, Frédérique, et al.
Publicado: (2009)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues
por: Maximos, Sarah, et al.
Publicado: (2017)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021)

Theoretical study of chemical reactivity descriptors of some repurposed drugs for COVID-19
por: Morad, Razieh, et al.
Publicado: (2023)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report
por: Del Toro-Pagán, Nicole Marie, et al.
Publicado: (2021)

Impact of Drug Induced Long QT Syndrome: A Systematic Review
por: Arunachalam, Karuppiah, et al.
Publicado: (2018)

Macrolide Treatment Failure due to Drug–Drug Interactions: Real-World Evidence to Evaluate a Pharmacological Hypothesis
por: Cicali, Brian, et al.
Publicado: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system
por: Sunaga, Tomiko, et al.
Publicado: (2021)

Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly
por: Bankes, David L., et al.
Publicado: (2020)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Drug-Induced Long-QT and Torsades de Pointes in Elderly Polymedicated Patients
por: García-Fuertes, Daniel, et al.
Publicado: (2016)

Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome
por: TeBay, Clifford, et al.
Publicado: (2022)

Drug-Induced QT Prolongation as a Result of an Escitalopram Overdose in a Patient with Previously Undiagnosed Congenital Long QT Syndrome
por: Singh, Paul, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gidfibdc6hfqpdmud8ibaua0dk